64Cu Hypoxia Imaging Radiotracer Targeting the Human Copper Transporter
NeuroMolecular Medicine · 29.06.2026 · 28 (1)
DOI: 10.1007/s12017-026-08939-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift NeuroMolecular Medicine, online erschienen am 29.06.2026. Verfasst von Shelly Meron und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Institute of Nanotechnology and Advanced Materials, Faculty of Exact Sciences, Bar-Ilan University, Ramat-Gan, 5290002, Isra…. Hauptthemen laut MEDLINE: Copper Radioisotopes, Radiopharmaceuticals, Cation Transport Proteins, Tumor Hypoxia. Die Arbeit nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bar-Ilan University.
Abstract (Originalsprache)
The detection and characterization of hypoxia through functional imaging represents a critical frontier in oncology, cardiology, and neurology. Despite extensive efforts, the clinical translation of a robust hypoxia imaging biomarker remains hindered by suboptimal signal limiting diagnostic accuracy. Here, we report the development of a 64 Cu-based radiotracer ( 64 Cu-CysPhe), which exploits the cellular copper uptake pathway involving the human copper transporter 1 (hCtr1). This targeted mechanism facilitates selective tracer accumulation in hypoxic tissues. In-vivo PET-MRI imaging in a murine breast cancer model demonstrated tumor-to-muscle ratios exceeding 3.0 up to 24 h post-injection. Notably, immunohistochemical analyses revealed that 64 Cu-CysPhe preferentially localizes to hypoxic tumor regions while excluding necrotic cores, thereby providing information about a tumor’s immediate microenvironment. Comparative analysis with established radiotracers, including 64 Cu-ATSM and 18 F-FDG, confirmed the sensitivity of 64 Cu-CysPhe in detecting hypoxic tumor regions. These findings establish 64 Cu-CysPhe as a promising candidate for non-invasive imaging of tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Institute of Nanotechnology and Advanced Materials, Faculty of Exact Sciences, Bar-Ilan University, Ramat-Gan, 5290002, Israel.
- The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, 5290002, Israel.
- The Gonda Multidisciplinary Brain Research Center, Bar-Ilan University, Ramat Gan, 5290002, Israel.
- The Paul Feder Laboratory for Alzheimer's disease research, Bar-Ilan University, Ramat Gan, 5290002, Israel.
- CNR-IOM at SISSA, Trieste, 34135, Italy.
- Wohl Institute for Translational Medicine, Hadassah Medical Center, Jerusalem, 91120, Israel.
ORCID-Profile: Sharon Ruthstein
Förderung
- Bar-Ilan University
Zitieren
APA
Meron, S., Shenberger, Y., Madar, R., Aupic, J., Abudi, N., Lapenta, F., Hirsch, M., Harel, O. O., Hofmann, L., Magistrato, A., Okun, E., Abramovitch, R., & Ruthstein, S. (2026). 64Cu Hypoxia Imaging Radiotracer Targeting the Human Copper Transporter. NeuroMolecular Medicine, 28(1). https://doi.org/10.1007/s12017-026-08939-4
Vancouver
Meron S, Shenberger Y, Madar R, Aupic J, Abudi N, Lapenta F, et al. 64Cu Hypoxia Imaging Radiotracer Targeting the Human Copper Transporter. NeuroMolecular Medicine. 2026;28(1). doi:10.1007/s12017-026-08939-4
BibTeX
@article{Meron2026,
author = {Meron, Shelly and Shenberger, Yulia and Madar, Ravit and Aupic, Jana and Abudi, Nathalie and Lapenta, Fabio and Hirsch, Melanie and Harel, Odelia Orbaum and Hofmann, Lukas and Magistrato, Alessandra and Okun, Eitan and Abramovitch, Rinat and Ruthstein, Sharon},
title = {64Cu Hypoxia Imaging Radiotracer Targeting the Human Copper Transporter},
journal = {NeuroMolecular Medicine},
year = {2026},
volume = {28},
number = {1},
doi = {10.1007/s12017-026-08939-4}
}
EUVIMED